Treatments for borderline ovarian tumours

The following are treatment options for the stages of borderline ovarian tumours. Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan.

Early stage borderline ovarian tumours

Surgery is the main treatment for early stage (stages 1 and 2) borderline tumours. The types of surgery done will depend on whether you want to get pregnant in the future.

The following may be offered to those who wish to become pregnant in future:

  • removing only the ovary with cancer and the fallopian tube on the same side (unilateral salpingo-oophorectomy)
  • removing only the part of ovary with the cyst containing the tumour (cystectomy or partial oophorectomy)

The following surgeries do not allow you to become pregnant in the future:

  • removing both ovaries and fallopian tubes (bilateral salpingo-oophorectomy)
  • removing the uterus, both ovaries and both fallopian tubes (total hysterectomy and bilateral salpingo-oophorectomy)

During surgery, the surgeon also removes abnormal-looking tissue samples from different parts of the pelvis, abdomen and lymph nodes. These samples are then analyzed in the lab to find out if the cancer has spread. This part of surgery is called surgical staging.

Advanced stage borderline ovarian tumours

Surgery is the main treatment for advanced stage (stages 3 and 4) borderline tumours. The types of surgery are:

  • total hysterectomy and bilateral salpingo-oophorectomy
  • surgical debulking (removing as much of the cancer as possible)

During surgery, the surgeon also removes abnormal-looking tissue samples from different parts of the pelvis, abdomen and lymph nodes. These samples are then analyzed in the lab to find out if the cancer has spread. This part of surgery is called surgical staging.

Further treatment with chemotherapy or radiation therapy is usually not given.

Recurrent borderline ovarian tumours

Recurrent borderline tumours means that the disease has come back after it has been treated. Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan.

Surgery is the main treatment for recurrent borderline tumours. Debulking surgery is done to remove as much of the tumour as possible.

Chemotherapy with carboplatin or cisplatin combined with other drugs such as paclitaxel may be given after surgery.

Clinical trials

Some clinical trials in Canada are open to women with ovarian cancer. Clinical trials look at new ways to prevent, find and treat cancer. Find out more about clinical trials.

Expert review and references

  • American Cancer Society. Ovarian Cancer. 2014. http://www.cancer.org/.
  • Cannistra SA, Gershenson DM, Recht A. Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. DeVita VT Jr, Lawrence TS, Rosenberg SA. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015: 76: 1075-1099.
  • Eskander RN, Diaz-Montes TP, Vang R, Armstrong DK, Bristow RE. Borderline tumors and other rare epithelial tumors of the ovary. Raghavan D, Blanke CD, Honson DH, et al (eds.). Textbook of Uncommon Cancer. 4th ed. Wiley Blackwell; 2012: 35: 497-506.
  • National Cancer Institute. Ovarian Low Malignant Potential Tumors Cancer Treatment for Health Professionals (PDQ®). 2015. https://www.cancer.gov/types/ovarian/hp/ovarian-low-malignant-treatment-pdq#section/all.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society